Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$7,267,351
-$687,215 QoQ
Shares Held
28,615
-12.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.53%
of 13F equity value
Holder Rank
#1,320
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STONEBRIDGE CAPITAL MANAGEMENT INC holds $14,542,000 across 7 Drug Manufacturers - General names. JNJ ranks #1 (50.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
28,615 | $7,267,351 | |
| 2 | MRK |
Merck & Co., Inc.
|
13,790 | $1,772,015 | |
| 3 | AMGN |
Amgen Inc
|
4,736 | $1,715,000 | |
| 4 | NVS |
Novartis AG
|
8,032 | $1,258,775 | |
| 5 | PFE |
Pfizer Inc
|
40,827 | $983,114 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,525 | $779,310 | |
| 7 | LLY |
ELI LILLY & Co
|
639 | $766,435 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,267,351 | 28,615 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $7,954,566 | 32,542 | Shares | Sole | 2026-04-14 | |
| 2025-06-30 | $5,911,272 | 38,699 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $6,417,842 | 38,699 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,912,644 | 40,884 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $6,641,867 | 40,984 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $6,004,837 | 41,084 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $6,530,715 | 41,284 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $6,443,424 | 41,109 | Shares | Sole | 2024-03-05 | |
| 2023-09-30 | $6,379,364 | 40,959 | Shares | Sole | 2023-12-13 | |
| 2023-06-30 | $7,303,073 | 44,122 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $6,972,675 | 44,985 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $8,745,941 | 49,510 | Shares | Sole | 2023-01-06 | |
| 2022-09-30 | $8,349,329 | 51,110 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $9,844,527 | 55,459 | Shares | Sole | 2022-07-01 | |
| 2022-03-31 | $10,319,216 | 58,225 | Shares | Sole | 2022-04-04 | |
| 2021-12-31 | $9,960,550 | 58,225 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $9,823,237 | 60,825 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $10,020,310 | 60,825 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $9,994,122 | 60,810 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $9,554,538 | 60,710 | Shares | Sole | 2021-01-06 | |
| 2020-09-30 | $8,978,951 | 60,310 | Shares | Sole | 2020-12-11 | |
| 2020-06-30 | $8,252,871 | 58,685 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $7,957,623 | 60,685 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||